Physician profile
Cameron Evans
NPI 1528447174
$6,098.19
in general payments reported to CMS, 2019-2025
16 companies · $596 in 2025
The $596 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,274 · 2020: $170 · 2021: $1,266 · 2022: $707 · 2023: $571 · 2024: $513 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,602 · Gift: $78.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.37 |
| Gift | $78.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,748.98 | 2019-2025 | Clareon, Clareon Panoptix Pro, Centurion |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,579.30 | 2019-2020 | |
| Glaukos Corporation | $522.15 | 2021-2025 | Idosetr, Istent Infinite, Photrexa Cross-Linking Kit |
| Biotissue Holdings INC. | $266.10 | 2020-2024 | |
| Aerie Pharmaceuticals, INC. | $250.68 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $160.41 | 2024 | Infuse |
| Shire North American Group INC | $115.43 | 2019 | |
| Vantage Technology LLC | $97.13 | 2023-2025 | |
| Coopervision INC. | $74.23 | 2025 | Myday Contact Lens |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Oyster Point Pharma, INC. | $60.55 | 2023-2024 | Tyrvaya |
| Abbvie INC. | $49.28 | 2025 | |
| Novartis Pharmaceuticals Corporation | $36.20 | 2020-2022 | |
| Rxsight INC | $35.78 | 2023-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Tearlab Corp | $24.50 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.